[go: up one dir, main page]

AR008391A1 - Derivados de catecol, su aplicacion terapeutica y medicamentos que los contienen - Google Patents

Derivados de catecol, su aplicacion terapeutica y medicamentos que los contienen

Info

Publication number
AR008391A1
AR008391A1 ARP970102549A ARP970102549A AR008391A1 AR 008391 A1 AR008391 A1 AR 008391A1 AR P970102549 A ARP970102549 A AR P970102549A AR P970102549 A ARP970102549 A AR P970102549A AR 008391 A1 AR008391 A1 AR 008391A1
Authority
AR
Argentina
Prior art keywords
acids
radicals
compounds
conjugates
strains
Prior art date
Application number
ARP970102549A
Other languages
English (en)
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19625524A external-priority patent/DE19625524C2/de
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of AR008391A1 publication Critical patent/AR008391A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/02—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups
    • C07C251/04—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C251/10—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of an unsaturated carbon skeleton
    • C07C251/16—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/547—Chelates, e.g. Gd-DOTA or Zinc-amino acid chelates; Chelate-forming compounds, e.g. DOTA or ethylenediamine being covalently linked or complexed to the pharmacologically- or therapeutically-active agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/58—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/60—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/58—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/64—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C245/00—Compounds containing chains of at least two nitrogen atoms with at least one nitrogen-to-nitrogen multiple bond
    • C07C245/02—Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides
    • C07C245/06—Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides with nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings
    • C07C245/08—Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides with nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings with the two nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings, e.g. azobenzene
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/02—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups
    • C07C251/24—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/72—Hydrazones
    • C07C251/74—Hydrazones having doubly-bound carbon atoms of hydrazone groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C251/78—Hydrazones having doubly-bound carbon atoms of hydrazone groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of an unsaturated carbon skeleton
    • C07C251/80—Hydrazones having doubly-bound carbon atoms of hydrazone groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of an unsaturated carbon skeleton the carbon skeleton containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/72—Hydrazones
    • C07C251/86—Hydrazones having doubly-bound carbon atoms of hydrazone groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyrrole Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Derivados de catecol de la formula general I en que radicales de ácidos azometincarboxílicos, ácidos azobencenoscarboxílicos, benzhidrazonas, ácidosaminobenzoicos, aminoácidos o dipéptidos, ácidos pirrolidin carboxílicos y/ooxazolidincarboxíl icos así como radicales de formilcarboximetiloximas actuancomo elementos estructurales y sus conjugados con sustancias activas, particularmente antibioticos. La invencion se refiere también a la aplicacionde estoscompuestos como sideroforo s en el caso de cepas bacterianas gram negativas, partivularmente pseudomonadáceas, cepas de E. colil, salmonella,klebsiella y proteus y en forma de sus conjugados con sustancias aactivas, por ejemplo antibioticos(como conjugados de siderofor o o antibiotico) puedenintroducir éstas en la célula bacteriana y mejorar su eficacia antibacteriana o promoverla en parte también frene a otras cepas de bacterias resistentes abeta-lactamas. Además estos compuestosson adecuados como quelatantes d e hierro para la utilizacion en enfermedades producidas en trastornos del metabolismodel hierro. Donde en la formula I R1=OH u O-acilo y R2 en posicion 3 y/o 4 radicales de ácidos azometincarboxílicos aromáticosradicales deazobencenocarboxílico s, radicales de benzohidrazona, radicales de ácidos aminobenzoicos, radicales de aminoácidos, radicales de ácidos pirrolidin y/ooxazolidincarboxílicos y radicales de formilcarboximetiloxima y /o susconjugados con sustancias activas, particularmente antibioticos. Estoscompuestos pueden existir en forma de ácidos libres en forma de sus sales o como ésteres facilmente disociables, aplicados en medicamentos que loscontienen. Se refiere tambiéna dichos medicamentos, así como a l a aplicacion de los mismos en el caso de trastornos infecciosos o producidos por alteraciones
ARP970102549A 1996-06-26 1997-06-11 Derivados de catecol, su aplicacion terapeutica y medicamentos que los contienen AR008391A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19625524A DE19625524C2 (de) 1996-06-26 1996-06-26 Neue synthetische Catechol-Antibiotika-Konjugate und diese enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
AR008391A1 true AR008391A1 (es) 2000-01-19

Family

ID=7798042

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970102549A AR008391A1 (es) 1996-06-26 1997-06-11 Derivados de catecol, su aplicacion terapeutica y medicamentos que los contienen

Country Status (29)

Country Link
US (1) US6380181B1 (es)
EP (1) EP0907633B1 (es)
JP (1) JP2000514042A (es)
KR (1) KR20000022120A (es)
CN (1) CN1106380C (es)
AR (1) AR008391A1 (es)
AT (1) ATE204563T1 (es)
AU (1) AU728669B2 (es)
BR (1) BR9709964A (es)
CA (1) CA2252809A1 (es)
CO (1) CO4900028A1 (es)
CZ (1) CZ9804297A3 (es)
DE (2) DE19654920A1 (es)
DK (1) DK0907633T3 (es)
ES (1) ES2163161T3 (es)
GR (1) GR3036667T3 (es)
HU (1) HUP0001746A3 (es)
IL (1) IL126703A0 (es)
NO (1) NO311975B1 (es)
NZ (1) NZ332519A (es)
PE (1) PE70098A1 (es)
PL (1) PL330899A1 (es)
PT (1) PT907633E (es)
RU (1) RU2180898C2 (es)
SK (1) SK283560B6 (es)
UA (1) UA54437C2 (es)
UY (1) UY24596A1 (es)
WO (1) WO1997049670A1 (es)
ZA (1) ZA975638B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19708846A1 (de) * 1997-03-05 1998-09-17 Gruenenthal Gmbh Neue Benzoxazindionderivate, Verfahren zu ihrer Herstellung und ihre Verwendung
US6613942B1 (en) 1997-07-01 2003-09-02 Novo Nordisk A/S Glucagon antagonists/inverse agonists
WO1999042435A2 (de) * 1998-02-21 1999-08-26 Analyticon Ag Biotechnologie Pharmazie Myxocheline
US20040186087A1 (en) * 2003-03-20 2004-09-23 Ceramoptec Industries, Inc. Siderophore conjugates of photoactive dyes for photodynamic therapy
DE102004030987A1 (de) * 2004-06-26 2006-01-12 Merck Patent Gmbh Ortho-substituierte (3-Hydroxyphenyl)-essigsäure-benzyliden-hydrazide
US20100240713A1 (en) * 2007-06-05 2010-09-23 Xenon Pharmaceuticals Inc. Aromatic and heteroaromatic compounds useful in treating iron disorders
US20090233972A1 (en) * 2008-03-12 2009-09-17 Yat Sun Or Substituted heterocycles as anti-infectives
EP3265130B1 (en) * 2014-08-19 2024-05-22 Hsiri Therapeutics, LLC Antibacterial sideromycins
US11857052B2 (en) * 2020-04-01 2024-01-02 Omachron Intellectual Property Inc. Water separator for a hair dryer

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU520351A1 (ru) * 1973-10-03 1976-07-05 Уральский Ордена Трудового Красного Знамени Политехнический Институт Имени С.М.Кирова Способ плучени азометинов
DE3215085A1 (de) 1982-04-22 1983-10-27 Bayer Ag, 5090 Leverkusen Ss-lactam-antibiotika, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
JPS59193822A (ja) 1983-04-15 1984-11-02 Kureha Chem Ind Co Ltd 腎炎治療剤
US4610824A (en) 1984-10-09 1986-09-09 E. R. Squibb & Sons, Inc. Hydrazide derivatives of monocyclic beta-lactam antibiotics
SU1520064A1 (ru) * 1985-01-14 1989-11-07 Эйсай Ко., Лтд (Фирма) Производные цефалоспорина в виде син-изомеров, про вл ющие антибактериальную активность
EP0189287B1 (en) * 1985-01-21 1992-12-16 Nippon Pharmaceutical Development Institute Company Limited Novel b-lactam antibiotics
ZA877987B (en) * 1986-11-12 1988-08-31 Ici Pharma Antibiotic compounds
GB8811055D0 (en) * 1988-05-10 1988-06-15 Ici Plc Antibiotic compounds
AU644008B2 (en) * 1990-08-10 1993-12-02 Sumitomo Pharmaceuticals Company, Limited Beta-lactam compounds, and their production and use
EP0544166A3 (en) 1991-11-26 1993-11-03 Hoffmann La Roche Cephalosporinderivatives
JPWO9318062A1 (en) * 1992-03-11 1994-03-03 Kyowa Hakko Kogyo Kk Peptide which inhibits phospholipase c.
DE4231295A1 (de) 1992-09-18 1994-03-24 Knoell Hans Forschung Ev Neue alpha-Aminoacylpenicilline mit substituierten Dicarboxamoyl-Seitenketten, Verfahren zu ihrer Herstellung und ihre Verwendung
DE4313946A1 (de) 1993-04-28 1994-11-03 Knoell Hans Forschung Ev Neue O-Acyl-N-(diacyloxybenzoyl)-amoxicillinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung

Also Published As

Publication number Publication date
NO985858D0 (no) 1998-12-14
KR20000022120A (ko) 2000-04-25
BR9709964A (pt) 1999-08-10
CO4900028A1 (es) 2000-03-27
DE59704380D1 (de) 2001-09-27
CN1106380C (zh) 2003-04-23
PL330899A1 (en) 1999-06-07
SK283560B6 (sk) 2003-09-11
JP2000514042A (ja) 2000-10-24
ES2163161T3 (es) 2002-01-16
HUP0001746A3 (en) 2000-11-28
DK0907633T3 (da) 2001-10-08
UY24596A1 (es) 2001-05-31
NZ332519A (en) 2000-05-26
UA54437C2 (uk) 2003-03-17
EP0907633B1 (de) 2001-08-22
US6380181B1 (en) 2002-04-30
DE19654920A1 (de) 1998-01-08
CA2252809A1 (en) 1997-12-31
RU2180898C2 (ru) 2002-03-27
CZ9804297A3 (cs) 2002-10-16
PT907633E (pt) 2002-02-28
SK178898A3 (en) 1999-06-11
HK1018613A1 (en) 1999-12-30
NO985858L (no) 1998-12-14
PE70098A1 (es) 1999-01-04
CN1222905A (zh) 1999-07-14
AU728669B2 (en) 2001-01-18
NO311975B1 (no) 2002-02-25
WO1997049670A1 (de) 1997-12-31
ATE204563T1 (de) 2001-09-15
AU2954297A (en) 1998-01-14
GR3036667T3 (en) 2001-12-31
EP0907633A1 (de) 1999-04-14
HUP0001746A2 (hu) 2000-10-28
IL126703A0 (en) 1999-08-17
ZA975638B (en) 1998-01-23

Similar Documents

Publication Publication Date Title
IL129237A0 (en) Use of mupirocin for the manufacture of a medicament for the treatment of bacterial infections associated with colonisation of the nasopharynx by pathogenic organisms
AR008391A1 (es) Derivados de catecol, su aplicacion terapeutica y medicamentos que los contienen
BR0008911A (pt) Bactérias patogênicas da cepa lactobacillus para a prevenção de diarréia
ES480914A1 (es) Un procedimiento para la preparacion de antibioticos de ce- falosporinas.
GT198304062A (es) Derivado epimerico de azahomoeritromicina a e intermedios del mismo
TR199901127T2 (xx) Antibakteriyel etkili 6-O-ikameli ketolitler.
NO951198D0 (no) Lipopeptidderivater, fremgangsmåte for fremstilling derav og anvendelse av derivatene
DE69930944D1 (de) Bacillus coagulans-zusammensetzung und deren verwendung
UY25780A1 (es) Nuevos antibióticos macrólidos
ES2042868T3 (es) Un metodo de producir galidermina.
BR0015177A (pt) ésteres de ácido benzóico de oxazolidinonas possuindo um substituinte hidroxiacetilpiperazina
BR9813317A (pt) Composto, composição farmacêutica para tratar infecções bacterianas, e, processos para tratar infecções bacterianas, e para preparar um composto
BR9812577A (pt) Composto, processo para preparar o mesmo, composição farmacêutica, e, processo para tratar infecções bacterianas
RU94030236A (ru) Производные 3 бета-алкенил-пенама, способ их получения, лекарственные средства и их применение для борьбы и предупреждения болезней
ES2182489T3 (es) Sales de calcio de antibioticos lipopeptidicos, procedimiento para su preparacion y utilizacion.
BR9912490A (pt) Composto, composição farmacêutica, processo para tratar doenças infecciosas, e uso do composto
RU2012143143A (ru) Пептидные соединения, пригодные для использования в качестве антибактериальных средств
AU2001291725A1 (en) Heterocyclic mutilin esters and their use as antibacterials
BR0006301A (pt) Macrólidos antibacterianos e pró-cinéticos
TW200634021A (en) 3,6-bicyclolides
ES8105147A1 (es) Procedimiento para la obtencion de composiciones farmaceuti-cas de actividad antibacteriana
ECSP972161A (es) Nuevos derivados sinteticos del catecol
AR021463A1 (es) Antibiotico de piridona con perfil de seguridad mejorado
BR9802894A (pt) Derivado de benzoxazindiona , aplicação de um derivado de benzoxazindiona e medicamento.
SE8000842L (sv) Nya antibiotika

Legal Events

Date Code Title Description
FB Suspension of granting procedure